Literature DB >> 11257508

Structural determinants outside the PXDLS sequence affect the interaction of adenovirus E1A, C-terminal interacting protein and Drosophila repressors with C-terminal binding protein.

D P Molloy1, P M Barral, K H Bremner, P H Gallimore, R J Grand.   

Abstract

C-Terminal binding protein (CtBP) interacts with a highly conserved amino acid motif (PXDLS) at the C terminus of adenovirus early region 1A (AdE1A) protein. This amino acid sequence has recently been demonstrated in the mammalian protein C-terminal interacting protein (CtIP) and a number of Drosophila repressors including Snail, Knirps and Hairy. In the study described here we have examined the structures of synthetic peptides identical to the CtBP binding sites on these proteins using NMR spectroscopy. It has been shown that peptides identical to the CtBP binding site in CtIP and at the N terminus of Snail form a series of beta-turns similar to those seen in AdE1A. The PXDLS motif towards the C terminus of Snail forms an alpha-helix. However, the motifs in Knirps and Hairy did not adopt well-defined structures in TFE/water mixtures as shown by the absence of medium range NOEs and a high proportion of signal overlap. The affinities of peptides for Drosophila and mammalian CtBP were compared using enzyme-linked immunosorbent assay. CtIP, Snail (N-terminal peptide) and Knirps peptides all bind to mammalian CtBP with high affinity (K(i) of 1.04, 1.34 and 0.52 microM, respectively). However, different effects were observed with dCtBP, most notably the affinity for the Snail (N-terminal peptide) and Knirps peptides were markedly reduced (K(i) of 332 and 56 microM, respectively) whilst the Hairy peptide bound much more strongly (K(i) for dCtBP of 6.22 compared to 133 microM for hCtBP). In addition we have shown that peptides containing identical PXDLS motifs but with different N and C terminal sequences have appreciably different affinities for mammalian CtBP and different structures in solution. We conclude that the factors governing the interactions of CtBPs with partner proteins are more complex than simple possession of the PXDLS motif. In particular the overall secondary structures and amino acid side chains in the binding sites of partner proteins are of importance as well as possible global structural effects in both members of the complex. These data are considered evidence for a multiplicity of CtBPs and partner proteins in the cell.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257508     DOI: 10.1016/s0167-4838(00)00071-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  A dissection of the teashirt and tiptop genes reveals a novel mechanism for regulating transcription factor activity.

Authors:  Rhea R Datta; Brandon P Weasner; Justin P Kumar
Journal:  Dev Biol       Date:  2011-10-08       Impact factor: 3.582

2.  Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis.

Authors:  Markus Kaller; Sven-Thorsten Liffers; Silke Oeljeklaus; Katja Kuhlmann; Simone Röh; Reinhard Hoffmann; Bettina Warscheid; Heiko Hermeking
Journal:  Mol Cell Proteomics       Date:  2011-05-12       Impact factor: 5.911

3.  CtBP is an essential corepressor for BCL6 autoregulation.

Authors:  Lourdes M Mendez; Jose M Polo; J Jessica Yu; Melissa Krupski; B Belinda Ding; Ari Melnick; B Hilda Ye
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

4.  The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.

Authors:  Sophie Deltour; Sébastien Pinte; Cateline Guerardel; Bohdan Wasylyk; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

5.  AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer.

Authors:  Rene Jackstadt; Simone Röh; Jens Neumann; Peter Jung; Reinhard Hoffmann; David Horst; Christian Berens; Georg W Bornkamm; Thomas Kirchner; Antje Menssen; Heiko Hermeking
Journal:  J Exp Med       Date:  2013-06-10       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.